ARA Avanti Rx Analytics

Medicinal Marihuana Science,

Redefined.


ARA – Avanti Rx Analytics Inc. is the first Health Canada GMP and OCDS licensed Contract Organization specializing in the field of controlled drugs and substances particularly in the area of Medicinal Marihuana, HEMP, Cannabinoids, and Marihuana based concentrated products.


ARA – Avanti Rx Analytics Inc. offers a comprehensive menu of services ranging from analytical R&D and QC testing, marihuana extraction under controlled environment, cannabinoids purification, cannabis infused-product formulation, and cannabis waste management by means of material denaturation, as well as the QA and regulatory consulting.


ARA – Avanti Rx Analytics Inc. as a Health Canada GMP and OCS licensed organization DOES NOT grow, distribute, nor sell/commercialize cannabis.


Our focus is in the provision of a broad range of sophisticated, state-of-the-art services to Health Canada licensed producers (LPs), government enforcement and regulatory agencies, and regulatory approved allied cannabis communities, and to continue to remain at the forefront of the healthcare industry, building an enviable reputation.


ARA – Avanti Rx Analytics Inc. is defined by:

  • A broad, innovative portfolio of platform-based technologies

  • A diversified commercial pipeline of customers

  • A high-performance team of experienced personnel

  • Advanced research and development capabilities

  • State of Art analytical and extraction facility

  • Health Canada GMP and OCDS licensed for critical analytical testing, extraction, and production

We are committed to setting the standards to ensure the safety, identity, strength, purity and quanlity (SISPQ) of cannabis and cannabis infused-products being distributed as “Medical Marihuana”.


We believe that ARA – Avanti Rx Analytics Inc. will:

  • Advance quality control and quality assurance for medical cannabis

  • Support the safe consumption of medical cannabis

  • Ensure transparency for our medical cannabis community

ARA – Avanti Rx Analytics Inc. is uniquely positioned to test, extract, develop, produce and supply cannabinoids that can enable and enhance the delivery and commercial success of your medicinal marihuana products. We look forward to working with you.


Our target services are carefully selected to ensure our resources, expertise and energy are focused on the opportunities that can bring the most benefit to all our stakeholders. We then rely on great science and passionate execution to bring these opportunities to fruition.



ARA ESTABLISHMENT LICENSES


  • Health Canada Controlled Drugs and Substances Licence

  • (Licence No. 2018/6927)

  • Health Canada Drug Establishment Licence (DEL)

  • (Licence No. 3-002313-A)

  • Health Canada Site Licence

  • (Licence No. 301860)

  • Health Canada Medical Device Establishment Licence

  • (Licence No. 7396)